Evidence map›Paper›PMID 34711069›Full record

SynthesisThe Journal of neuropsychiatry and clinical neurosciences2022

Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Sara Paredes-Echeverri, Julie Maggio, Indrit Bègue, Susannah Pick, Timothy R Nicholson, David L Perez

Erratum issuedOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of neuropsychiatry and clinical neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Iatrogenic harm in functional neurological disorder.Brain : a journal of neurology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sara Paredes-EcheverriFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).ORCID 0000-0001-5163-4730
Julie MaggioFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Indrit BègueFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Susannah PickFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Timothy R NicholsonFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
David L PerezFunctional Neurological Disorder Research Program, Cognitive Behavioral Neurology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Paredes-Echeverri, Maggio, Perez); Department of Physical Therapy, Massachusetts General Hospital, Boston (Maggio); Adult Psychiatry Division, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland (Bègue); Laboratory for Clinical and Experimental Psychopathology, Department of Psychiatry, University of Geneva, Switzerland (Bègue); Institute of Psychiatry, Psychology and Neuroscience, King's College, London (Pick, Nicholson); and Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).ORCID 0000-0003-2721-583X
Massachusetts General Hospital · US

Funding

Neuroimaging Biomarkers of Symptom Severity, Adverse Life Events and Prognosis in Motor Functional Neurological DisordersK23MH111983 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PEREZ, DAVID LEWIS · 2017 to 2021
$998k
Medical Research Council MR/V032771/1NIMH NIH HHS K23 MH111983
6 · The paper itself

Abstract

objectiveFunctional neurological disorder (FND) is a core neuropsychiatric condition. To date, promising yet inconsistently identified neural circuit profiles have been observed in patients with FND, suggesting that gaps remain in our systems-level neurobiological understanding. As such, other important physiological variables, including autonomic, endocrine, and inflammation findings, need to be contextualized for a more complete mechanistic picture.

methodsThe investigators conducted a systematic review and meta-analysis of available case-control and cohort studies of FND. PubMed, PsycINFO, and Embase databases were searched for studies from January 1, 1900, to September 1, 2020, that investigated autonomic, endocrine, and inflammation markers in patients with FND. Sixty-six of 2,056 screened records were included in the review, representing 1,699 patients; data from 20 articles were used in the meta-analysis.

resultsFindings revealed that children and adolescents with FND, compared with healthy control subjects (HCs), have increased resting heart rate (HR); there is also a tendency toward reduced resting HR variability in patients with FND across the lifespan compared with HCs. In adults, peri-ictal HR differentiated patients with functional seizures from those with epileptic seizures. Other autonomic and endocrine profiles for patients with FND were heterogeneous, with several studies highlighting the importance of individual differences.

conclusionsInflammation research in FND remains in its early stages. Moving forward, there is a need for the use of larger sample sizes to consider the complex interplay between functional neurological symptoms and behavioral, psychological, autonomic, endocrine, inflammation, neuroimaging, and epigenetic/genetic data. More research is also needed to determine whether FND is mechanistically (and etiologically) similar or distinct across phenotypes.

Indexed as

Conversion DisorderNervous System DiseasesAdolescentCohort StudiesHumansInflammationNeuroimagingSeizuresConversion DisorderCortisolFunctional Neurological DisorderHeart RateInflammationPsychogenic Nonepileptic Seizures

Identifiers

PMID34711069
PMCPMC8813876
OpenAlexW3175646162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.